Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Asthma Treatment Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Asthma Treatment Market Analysis and Forecast, 2017–2027


5. Market Outlook

5.1. Pipeline Analysis

5.2. Reimbursement Scenario

5.3. Disease Prevalence with Key Countries


6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

6.3.1. Long-term Asthma Control Medications

6.3.1.1. Inhaled Corticosteroids

6.3.1.2. Leukotriene Modifiers

6.3.1.3. Long-acting Beta Agonists

6.3.1.4. Combination Inhalers

6.3.1.5. Theophylline

6.3.1.6. Others (reslizumab, benralizumab, etc.)

6.3.2. Quick-relief (rescue) Medications

6.3.2.1. Short-acting Beta Agonists

6.3.2.2. Ipratropium (Atrovent)

6.3.2.3. Oral and Intravenous Corticosteroids

6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type


7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2017–2027

7.3.1. Oral

7.3.2. Inhaled

7.3.3. Intravenous

7.3.4. Subcutaneous

7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration


8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel


9. Global Asthma Treatment Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Asthma Treatment Market Attractiveness, by Region


10. North America Asthma Treatment Market Analysis and Forecast

10.1. Introduction

10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

10.2.1. Long-term Asthma Control Medications

10.2.1.1. Inhaled Corticosteroids

10.2.1.2. Leukotriene Modifiers

10.2.1.3. Long-acting Beta Agonists

10.2.1.4. Combination Inhalers

10.2.1.5. Theophylline

10.2.1.6. Others (reslizumab, benralizumab, etc.)

10.2.2. Quick-relief (rescue) Medications

10.2.2.1. Short-acting Beta Agonists

10.2.2.2. Ipratropium (Atrovent)

10.2.2.3. Oral and Intravenous Corticosteroids

10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

10.3.1. Oral

10.3.2. Inhaled

10.3.3. Intravenous

10.3.4. Subcutaneous

10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Asthma Treatment Market Attractiveness Analysis

10.6.1. By Treatment Type

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country/Sub-region


11. Europe Asthma Treatment Market Analysis and Forecast

11.1. Introduction

11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

11.2.1. Long-term Asthma Control Medications

11.2.1.1. Inhaled Corticosteroids

11.2.1.2. Leukotriene Modifiers

11.2.1.3. Long-acting Beta Agonists

11.2.1.4. Combination Inhalers

11.2.1.5. Theophylline

11.2.1.6. Others (reslizumab, benralizumab etc.)

11.2.2. Quick-relief (rescue) Medications

11.2.2.1. Short-acting Beta Agonists

11.2.2.2. Ipratropium (Atrovent)

11.2.2.3. Oral and Intravenous Corticosteroids

11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

11.3.1. Oral

11.3.2. Inhaled

11.3.3. Intravenous

11.3.4. Subcutaneous

11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Asthma Treatment Market Attractiveness Analysis

11.6.1. By Treatment Type

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Asthma Treatment Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

12.2.1. Long-term Asthma Control Medications

12.2.1.1. Inhaled Corticosteroids

12.2.1.2. Leukotriene Modifiers

12.2.1.3. Long-acting Beta Agonists

12.2.1.4. Combination Inhalers

12.2.1.5. Theophylline

12.2.1.6. Others (reslizumab, benralizumab etc.)

12.2.2. Quick-relief (rescue) Medications

12.2.2.1. Short-acting Beta Agonists

12.2.2.2. Ipratropium (Atrovent)

12.2.2.3. Oral and Intravenous Corticosteroids

12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

12.3.1. Oral

12.3.2. Inhaled

12.3.3. Intravenous

12.3.4. Subcutaneous

12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis

12.6.1. By Treatment Type

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Asthma Treatment Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

13.2.1. Long-term Asthma Control Medications

13.2.1.1. Inhaled Corticosteroids

13.2.1.2. Leukotriene Modifiers

13.2.1.3. Long-acting Beta Agonists

13.2.1.4. Combination Inhalers

13.2.1.5. Theophylline

13.2.1.6. Others (reslizumab, benralizumab etc.)

13.2.2. Quick-relief (rescue) Medications

13.2.2.1. Short-acting Beta Agonists

13.2.2.2. Ipratropium (Atrovent)

13.2.2.3. Oral and Intravenous Corticosteroids

13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

13.3.1. Oral

13.3.2. Inhaled

13.3.3. Intravenous

13.3.4. Subcutaneous

13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Asthma Treatment Market Attractiveness Analysis

13.6.1. By Treatment Type

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region


14. Middle East & Africa Asthma Treatment Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

14.2.1. Long-term Asthma Control Medications

14.2.1.1. Inhaled Corticosteroids

14.2.1.2. Leukotriene Modifiers

14.2.1.3. Long-acting Beta Agonists

14.2.1.4. Combination Inhalers

14.2.1.5. Theophylline

14.2.1.6. Others (reslizumab, benralizumab etc.)

14.2.2. Quick-relief (rescue) Medications

14.2.2.1. Short-acting Beta Agonists

14.2.2.2. Ipratropium (Atrovent)

14.2.2.3. Oral and Intravenous Corticosteroids

14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

14.3.1. Oral

14.3.2. Inhaled

14.3.3. Intravenous

14.3.4. Subcutaneous

14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

14.5.1. GCC

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis

14.6.1. By Treatment Type

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Market Share Analysis, by Company (2018)

15.2. Company Profiles

15.2.1. AstraZeneca

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Company Financials

15.2.1.3. Growth Strategies

15.2.1.4. SWOT Analysis

15.2.2. Boehringer Ingelheim International GmbH

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Company Financials

15.2.2.3. Growth Strategies

15.2.2.4. SWOT Analysis

15.2.3. GlaxoSmithKline plc

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Company Financials

15.2.3.3. Growth Strategies

15.2.3.4. SWOT Analysis

15.2.4. Novartis AG

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Company Financials

15.2.4.3. Growth Strategies

15.2.4.4. SWOT Analysis

15.2.5. Teva Pharmaceutical Industries Ltd

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Company Financials

15.2.5.3. Growth Strategies

15.2.5.4. SWOT Analysis

15.2.6. Sumitomo Dainippon Pharma Co., Ltd

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Company Financials

15.2.6.3. Growth Strategies

15.2.6.4. SWOT Analysis

15.2.7. Merck & Co., Inc.

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Company Financials

15.2.7.3. Growth Strategies

15.2.7.4. SWOT Analysis

15.2.8. F. Hoffmann-La Roche Ltd.

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Company Financials

15.2.8.3. Growth Strategies

15.2.8.4. SWOT Analysis

15.2.9. Sanofi

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Company Financials

15.2.9.3. Growth Strategies

15.2.9.4. SWOT Analysis

15.2.10. Mylan N.V.

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Company Financials

15.2.10.3. Growth Strategies

15.2.10.4. SWOT Analysis



List of Figures



Figure 01: Global Asthma Treatment Market Value (US$ Mn) and Distribution Channel, by Region, 2018 and 2027

Figure 02: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 03: Global Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 04: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Long-term Asthma Control Medications, 2017–2027

Figure 05: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Quick-relief (rescue) Medications, 2017–2027

Figure 06: Global Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 07: Global Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 08: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhaled, 2017–2027

Figure 09: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017–2027

Figure 10: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2017–2027

Figure 11: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2017–2027

Figure 12: Global Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 13: Global Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 14: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027

Figure 15: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027

Figure 16: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027

Figure 17: Global Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 18: Global Asthma Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 19: Global Asthma Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 20: North America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 21: North America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 22: North America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 23: North America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 24: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 25: North America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 26: North America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 27: North America Asthma Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America Asthma Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 29: Europe Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 30: Europe Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 31: Europe Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 32: Europe Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 33: Europe Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 34: Europe Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 35: Europe Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 36: Europe Asthma Treatment Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027

Figure 37: Europe Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 39: Asia Pacific Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 40: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2017–2027

Figure 41: Asia Pacific Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 42: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 43: Asia Pacific Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 44: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 - 2027

Figure 45: Asia Pacific Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47: Latin America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 48: Latin America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 49: Latin America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 50: Latin America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 51: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 52: Latin America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 53: Latin America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 54: Latin America Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 56: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 57: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 58: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 59: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 60: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 61: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 62: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019?2027

Figure 63: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 65: Global Asthma Treatment Market Share, by Company, 2018

Figure 66: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 67: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 68: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018

Figure 69: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018

Figure 71: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 72: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018

Figure 73: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 74: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018

Figure 75: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 76: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018

Figure 77: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 78: Novartis AG Breakdown of Net Sales (%), by Country, 2018

Figure 79: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 80: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018

Figure 81: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 83: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Segment, 2018

Figure 84: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 85: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017

Figure 86: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 87: Breakdown of Sumitomo Dainippon Pharma Co., Ltd Net Sales (%), by Product Segment, 2017

Figure 88: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 90: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 91: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 92: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 93: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2018

Figure 94: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 95: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 96: Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 97: Sanofi Breakdown of Net Sales (%), by Region, 2018

Figure 98: Sanofi Revenue Breakdown of Net Sales (%), by Business segment, 2018

Figure 99: Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 100: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 101: Mylan N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 102: Mylan N.V. Breakdown of Net Sales (%), by Region, 2018


List of Tables



Table 01: Pipeline Analysis

Table 02: Pipeline Analysis

Table 03: Pipeline Analysis

Table 04: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 05: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 06: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 07: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 08: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 09: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 10: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 11: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 12: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 13: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 14: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 17: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 18: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 19: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 20: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 21: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 23: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 24: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 25: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 26: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 27: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 28: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 29: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 30: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 31: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 32: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 33: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 35: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 36: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 37: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 38: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 39: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027